Esmail D. Zanjani (1938–2019): Architect of In Utero Stem Cell Therapy
Esmail D. Zanjani was a titan of hematology and regenerative medicine whose work bridged the gap between basic developmental biology and clinical application. Over a career spanning five decades, Zanjani transformed our understanding of how blood is formed and pioneered the controversial yet groundbreaking field of in utero stem cell transplantation. His vision was to treat genetic diseases before a child was even born, effectively curing disorders in the womb.
1. Biography: From Tehran to the High Desert
Esmail D. Zanjani was born in 1938 in Iran. He moved to the United States for his higher education, a move that would define the trajectory of modern hematology. He earned his Bachelor of Science from New York University (NYU) in 1964, followed by a Ph.D. from the same institution in 1969.
His academic career was marked by steady ascent through some of America’s most prestigious research institutions:
- NYU School of Medicine: He began his faculty career here, focusing on the hormonal regulation of red blood cell production.
- University of Minnesota: In the late 1970s and 1980s, he moved to Minnesota, a hub for transplant biology, where he began refining his theories on fetal medicine.
- University of Nevada, Reno (UNR): In 1990, Zanjani joined UNR, where he spent the remainder of his career. He served as a Professor and Chair of the Department of Animal Biotechnology and held a joint appointment with the VA Sierra Nevada Health Care System.
Zanjani remained active in research until his passing in 2019, leaving behind a legacy as a "scientist’s scientist"—rigorous, humble, and relentlessly curious.
2. Major Contributions: Healing Before Birth
Zanjani’s primary contribution to science was the development of In Utero Hematopoietic Stem Cell Transplantation (IUHSCT).
The Sheep Model:
Zanjani recognized that the sheep fetus provided a near-perfect physiological model for human pregnancy. He developed a technique to inject human stem cells into fetal lambs. Because the fetal immune system is not yet fully "educated" to recognize self from non-self, the lamb’s body would accept the human cells without rejection.
Human-Sheep Chimeras:
His most famous (and sometimes controversial) breakthrough was the creation of "chimeric" sheep—animals that possessed a small percentage of human cells. This was not a pursuit of science fiction, but a practical methodology to:
- Expand human stem cells: Using the lamb as a "bioreactor" to grow large quantities of human cells.
- Study organ development: Observing how human cells integrated into the liver, heart, and brain of the sheep to understand how to grow transplantable human organs in the future.
Erythropoiesis Regulation:
Earlier in his career, Zanjani made significant strides in understanding Erythropoietin (EPO), the hormone that stimulates red blood cell production. His work helped map the transition of EPO production from the liver (in the fetus) to the kidneys (in the adult).
3. Notable Publications
Zanjani authored over 300 scientific papers. Some of his most influential works include:
- "Erythropoietin production in the fetus: role of the kidney and liver" (1977, Journal of Clinical Investigation): A foundational paper explaining how the site of blood production shifts during development.
- "Engraftment and proliferation of human hemopoietic stem cells in sheep" (1992, Blood): This landmark study proved that human stem cells could survive and multiply within a different species' fetus.
- "In utero transplantation of fetal liver haemopoietic stem cells in sheep" (1986, Nature): One of the earliest proofs of concept for prenatal transplantation.
- "The human-sheep chimeras as a model for human stem cell mobilization and gene therapy" (2000s): A series of papers exploring how these models could be used to cure diseases like Sickle Cell Anemia and Thalassemia.
4. Awards & Recognition
While Zanjani did not seek the spotlight, the scientific community recognized his profound impact with several prestigious honors:
- The William S. Middleton Award (2006): The highest honor bestowed by the Department of Veterans Affairs (VA) for outstanding achievement in biomedical research.
- Established the COBRE: He was the founding director of the Center of Biomedical Research Excellence (COBRE) at the University of Nevada, funded by the NIH, which focused on stem cell biology.
- Society Memberships: He was a prominent Fellow of the American Association for the Advancement of Science (AAAS) and held leadership roles in the International Society for Experimental Hematology (ISEH).
5. Impact & Legacy
Zanjani’s legacy is twofold: clinical hope and ethical dialogue.
Clinical Impact:
His work laid the groundwork for current clinical trials in fetal therapy. Today, doctors are using the principles Zanjani established to treat conditions like Alpha Thalassemia Major by performing stem cell transplants while the fetus is still in the womb, preventing the severe organ damage that occurs before birth.
The "Chimera" Debate:
By creating animals with human cells, Zanjani forced the scientific community and the public to confront the ethics of xenotransplantation and interspecies research. His work directly influenced the development of NIH guidelines on chimera research, ensuring that such work is done with strict oversight.
6. Collaborations
Zanjani was known for his long-term partnership with Dr. Graça Almeida-Porada, who was not only his primary research collaborator but also his wife. Together, they ran the "Zanjani-Porada Lab," which became a global destination for stem cell researchers.
He also collaborated extensively with:
- E. Donnall Thomas: The Nobel Prize-winning pioneer of bone marrow transplantation, with whom Zanjani consulted on the limits of graft-versus-host disease.
- The NIH and VA: He was a bridge between federal research funding and academic execution, mentoring dozens of Ph.D. students who now lead their own labs in regenerative medicine.
7. Lesser-Known Facts
- The "85% Human" Myth: In the mid-2000s, sensationalist media outlets claimed Zanjani had created a sheep that was "85% human." In reality, the human cell contribution was usually between 1% and 10% in specific organs. Zanjani spent much of his later career correcting this misconception, emphasizing that the goal was medical utility, not creating "human-animals."
- A "Gentle Giant": Despite his high-stakes research, colleagues frequently described him as incredibly soft-spoken and humble.
He was known for spending hours in the barn personally checking on his sheep, treating the animals with immense care and respect.
- Dual-Purpose Science: Much of his work was funded by the Veterans Affairs (VA) because of its potential to treat veterans with blood cancers and organ failure, proving that fetal research has profound implications for adult medicine.